<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168903">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00898235</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000632869</org_study_id>
    <secondary_id>BUMC-H-22838</secondary_id>
    <nct_id>NCT00898235</nct_id>
  </id_info>
  <brief_title>Collecting Samples From Patients With Primary Systemic Amyloidosis</brief_title>
  <official_title>Data, Tissue, Blood, and Urine Repository for Amyloid Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients with
      primary systemic amyloidosis to test in the laboratory may help the study of this disease in
      the future.

      PURPOSE: This research study is collecting samples from patients with primary systemic
      amyloidosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  To establish and maintain a database of clinical material (i.e., blood, urine, and
           tissue) and information on patients with primary systemic amyloidosis.

      OUTLINE: Blood, urine, tissue, and bone marrow samples are collected during standard
      laboratory evaluations to maintain a repository of biospecimens in the Gerry Amyloid
      Research Laboratory, to permit the correlation of clinical results with measured biological
      events, and for future research studies. Bone marrow RNA samples are examined for
      immunoglobulin light-chain gene sequences and amino acids by PCR and positional cloning.
      Blood serum and urine samples are evaluated for amyloid protein stability by high-resolution
      calorimetry, isothermal-titration calorimetry, and far- and near-UV circular dichroism and
      fluorescence spectroscopy. Urine samples are also examined for post-translational
      modifications (e.g., glycosylation, sulfation, and cross-linking) to identify common
      features unique to amyloid proteins. Tissue samples are analyzed for biochemical and
      biophysical properties and for post-translational modifications in light chains.

      Quality of life is assessed by the SF36 questionnaire.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2000</start_date>
  <completion_date type="Anticipated">February 2037</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Establish a repository to promote biochemical research</measure>
    <time_frame>life of study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collection of clinical material and information</measure>
    <time_frame>life of study</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Multiple Myeloma</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>clonality analysis</intervention_name>
    <description>analyze clonality</description>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>polymerase chain reaction</intervention_name>
    <description>analyze polymerase chain reaction</description>
  </intervention>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>protein analysis</intervention_name>
    <description>analyze protein</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biologic sample preservation procedure</intervention_name>
    <description>preserve biologic samples</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>laboratory biomarker analysis</intervention_name>
    <description>analyze laboratory biomarkers</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fluorescence spectroscopy</intervention_name>
    <description>perform fluorescence spectroscopy on specimens</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
    <description>assess quality of life at each follow-up for life</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood, urine, and tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants diagnosed, or with suspicion of having, primary systemic amyloidosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        DISEASE CHARACTERISTICS:

          -  Diagnosis or suspicion of primary systemic amyloidosis

        PATIENT CHARACTERISTICS:

          -  Referred to the Amyloid Treatment and Research Center at Boston University Medical
             Center

        PRIOR CONCURRENT THERAPY:

          -  Not specified

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vaishali Sanchorawala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salli Fennessey</last_name>
    <phone>617-638-8261</phone>
    <email>sally.fennessey@bmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston University Cancer Research Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Trials Office - Boston University Cancer Research Cen</last_name>
      <phone>617-638-8265</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 19, 2016</lastchanged_date>
  <firstreceived_date>May 9, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Medical Center</investigator_affiliation>
    <investigator_full_name>Vaishali Sanchorawala</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>primary systemic amyloidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
